evipedia.ai
← Back

R-Lipoic Acid for Health & Longevity

Created on 11/04/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

R-lipoic acid, the natural form of a molecule cells use for energy, is a supplement sold for healthy aging. Human evidence for this pure form is thin: one longer study found a modest drop in weight relative to height in overweight adults. Small, inconsistent blood-sugar improvements and short-term nerve-symptom relief come from the mixed form. Stomach upset is commonest; rare immune reactions can harm kidneys or dangerously lower blood sugar. (Full Review)

Protocol

Trial dose (R-form)
600 mg/day
For 24 weeks in overweight adults; retail capsules of 100 mg allow lower doses
Time of day
Morning, empty stomach
As in the R-form trial protocol
Single versus split doses
Once daily in trials
Splitting doses is commonly used to ease gastrointestinal upset
Time to effect
Weight changes
Over 24 weeks
Emerged in the R-form trial
Neuropathy symptom relief
Within 5 weeks
Mixed form; little effect at six months

Benefits

Contraindications
  • Known hypersensitivity to lipoic acid (thioctic acid)
  • Prior insulin autoimmune syndrome or known HLA-DRB1*04:06/*04:03 carriage
  • Existing proteinuria, membranous nephropathy or chronic kidney disease
  • Children and adolescents
  • Pregnancy and breastfeeding
  • Uncorrected thiamine deficiency (e.g., alcohol use disorder)
    •
Key Interactions
  • Insulin and oral glucose-lowering drugs (metformin, glibenclamide): enhanced glucose lowering
  • Cisplatin: possible loss of efficacy
  • Mineral supplements and dairy (iron, magnesium, calcium): reduced absorption
  • Metal-containing antacids (aluminum hydroxide): reduced lipoic acid effect
  • Creatine: greater muscle creatine loading
  • Food: lowers absorption
  • Alcohol (heavy, regular use): severe poisoning above 10 g, reduced treatment success
    •
Theoretical (inferred from mechanism)
  • Thyroid hormone (levothyroxine): could alter thyroid levels
  • Other chemotherapy relying on oxidative damage (doxorubicin): possibly reduced efficacy
  • Biotin and pantothenic acid: could reduce uptake of either
  • Glucose-lowering supplements (berberine): additive blood-sugar lowering
  • Acetyl-L-carnitine: possible blood-pressure lowering
    •

Risk & Side Effects

  • High:
  • Medium:
  • Low: Gastrointestinal Upset; Membranous Nephropathy and Proteinuria; Insulin Autoimmune Syndrome; Allergic and Hypersensitivity Reactions; Acute Overdose Toxicity; Drug-Induced Liver Injury; Dizziness and Other Label-Listed Reactions
    •
  • Speculative: Biotin Depletion; Toxicity in Thiamine Deficiency; Shortened Lifespan in Accelerated-Aging Mice
    •

Monitoring

Marker Target Why
Urine albumin-to-creatinine ratio <30 mg/g creatinine Safety check: new proteinuria stops use
Serum creatinine 0.6–1.2 mg/dL Safety check: rising value stops use
Fasting glucose 70–99 mg/dL Expected to change; low values are a safety check
HbA1c 4.0–5.6% Expected to change (small decrease)
Insulin and insulin autoantibodies Negative autoantibodies Safety check: positive result with hypoglycemia stops use
Body weight and waist circumference No established target; track change from own baseline Expected to change (modest loss)

Cadence: Baseline panel; urine protein and glucose at 3, 6, 9 and 12 months, then every 6–12 months; weight and waist monthly for the first 6 months; insulin and insulin autoantibodies immediately if fasting or nighttime hypoglycemia occurs

Qualitative Assessment

  • Gastrointestinal comfort (nausea, reflux, indigestion)
  • Nerve symptoms such as burning, tingling or numbness, if present at baseline
  • Energy levels and exercise tolerance
  • Episodes of shakiness, sweating or confusion suggesting low blood sugar
  • New leg or ankle swelling or foamy urine suggesting kidney protein loss
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.